Department of Radiology, University Hospital Regensburg, Regensburg, Germany.
Clin Hemorheol Microcirc. 2019;73(1):73-83. doi: 10.3233/CH-199224.
Evaluation of the post-interventional success following ablative techniques (radiofrequency and microwave) using a new color coded perfusion quantification software with CEUS in patients with primary and secondary liver malignancies.
75 patients (60 males, 15 females, age 24-84 years, mean 62.7 years) with 128 malignant liver lesions were included in this study. Between 01/2013 and 06/2018, the therapeutic interventional procedure in 88 lesions was MWA, in 40 lesions RFA. All patients underwent CEUS using a convex multifrequency probe (1-6 MHz) following application of 1-2.4 ml sulphur hexaflouride microbubbles, before and within 24 hours following RFA and MWA to detect residual tumor tissue. Postprocessing of the stored DICOM loops from 15 sec up to 1 min using a perfusion quantification software regarding peak enhancement (pE), time to peak (TTP), mean transit time (MTT), rise time (Ri) and Wash-in area under the curve (WiAUC) in the center of the lesion, the border area and periphery was performed.
In patients treated with RFA, pE differences between center of the lesion vs. surrounding liver were found to be statistically extremely significant (p < 0.001), differences between center of the lesion and margin were also statistically significant (p < 0.01). mTT, TTP, WiAuC and Ri showed no significant difference between center, margin or surrounding liver.In patients treated with MWA, statistically significant differences (p < 0.05) were found for pE, Ri and mTT regarding the differences between center of lesion and surrounding tissue. WiAuC and TTP showed no significant differences between center, margin or surrounding liver.
CEUS with perfusion imaging is a valuable supporting tool for post-interventional success control following RFA and MWA of primary and secondary liver maligancies. Focus should be placed upon pE following MWA and pE, Ri and mTT following RFA.
使用新的彩色编码灌注量化软件结合超声造影(CEUS)评估原发性和继发性肝恶性肿瘤消融治疗后的介入治疗效果。
本研究纳入了 75 名患者(60 名男性,15 名女性,年龄 24-84 岁,平均 62.7 岁),共 128 个恶性肝肿瘤。在 2013 年 1 月至 2018 年 6 月期间,88 个肿瘤接受微波消融(MWA)治疗,40 个肿瘤接受射频消融(RFA)治疗。所有患者均在 RFA 和 MWA 治疗前后以及治疗后 24 小时内,应用 1-2.4ml 六氟化硫微泡进行 CEUS 检查,使用凸阵多频探头(1-6MHz)检测残余肿瘤组织。使用灌注量化软件对存储的 DICOM 循环进行 15 秒至 1 分钟的后处理,分析病变中心、边缘和周围的峰值增强(pE)、达峰时间(TTP)、平均渡越时间(MTT)、上升时间(Ri)和 Wash-in 曲线下面积(WiAUC)。
在接受 RFA 治疗的患者中,病变中心与周围肝组织的 pE 差异具有统计学意义(p<0.001),病变中心与边缘的 pE 差异也具有统计学意义(p<0.01)。MTT、TTP、WiAUC 和 Ri 在病变中心、边缘和周围肝组织之间无显著差异。在接受 MWA 治疗的患者中,病变中心与周围组织之间的 pE、Ri 和 mTT 差异具有统计学意义(p<0.05)。WiAUC 和 TTP 在病变中心、边缘和周围肝组织之间无显著差异。
CEUS 灌注成像对原发性和继发性肝恶性肿瘤的消融治疗后介入治疗效果的评估是一种有价值的辅助工具。重点应放在 MWA 后的 pE、RFA 后的 pE、Ri 和 mTT 上。